Tag:
Orexin
Latest Headlines
Latest Headlines
Merck confronts tough odds pioneering experimental sleep drug
Last year Americans spent $2 billion on sleep drugs, a big drop from the $3.6 billion recorded by IMS Health back in 2006. The reason for the plunge is simple: Longtime standard treatments like
Actelion sees positive results in new sleep trial
Actelion says its experimental sleep therapy has performed well in a clinical trial, raising the prospects of a new class of sleep drugs that inhibit orexin, a chemical in the brain believed to keep
